PK Papyrus
Device Cardiology/Vascular Diseases
PDI 07640130447257
General payments
$469,344
Research payments
$222,297
Through program year 2025, $469,344 in general payments and $222,297 in research payments were reported against PK Papyrus (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $12,926 | 46 |
| 2025 | Research | $222,297 | 259 |
| 2024 | General | $205,026 | 96 |
| 2023 | General | $39,627 | 216 |
| 2022 | General | $52,035 | 822 |
| 2021 | General | $159,729 | 1,612 |
Breakdown
The top 5 of 41 recipients; each share is of general payments naming this product in 2025.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,792 general · 259 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.